Mr. Cameron Groome reports
MICROBIX ANNOUNCES QUALITY PRODUCTS DISTRIBUTION AGREEMENT
Microbix Biosystems Inc. has appointed The Medical Supply Company of Ireland (MSC) as a distributor.
Under an agreement between the parties, MSC has been appointed as distributor of Microbix's quality assessment products (QAPs) for the Republic of Ireland and Northern Ireland. As distributor, MSC will provide marketing, distribution and logistical support for Microbix's QAPs. At present, there are four dozen such QAPs across the Proceedx and Redx Controls trade names to support the whole process accuracy of tests for bacterial and viral diseases by emulating patient samples while being consistent, non-infectious and stable.
MSC is a privately owned life sciences distribution company with highly trained technical salespeople providing analytical consumables, diagnostic equipment and other solutions to customers in the fields of life science and clinical diagnostics. MSC is particularly interested in Microbix's human papilloma virus (HPV) and mycoplasma genitalium (MGEN) control products, two diseases at the forefront of sexual health testing, as MSC services a number of clinical laboratories performing these tests using equipment from manufacturers that have verified the performance of those Microbix products.
Phil Casselli, senior vice-president of sales and business development of Microbix, stated: "We're pleased to have MSC become a distribution partner for our QAPs product lines. They are the major provider of laboratory supply materials, diagnostic Controls and technical support for the Republic of Ireland and Northern Ireland, with well-trained marketing and sales staff and a team of field service professionals. Microbix believes MSC will provide QAPs customers with excellent user training and after sales support for our growing Proceedx and Redx Controls product lines."
Lisa Tang, life sciences sales manager for MSC, also commented: "We're excited to be providing Microbix's innovative QAPs to our diagnostics customers. These QAPs will complement our portfolio of Controls and supplies for sexually transmitted, respiratory, gastrointestinal and hospital-acquired pathogens. Training of MSC staff about QAPs is under way and we're now stocking these products for our customers."
About Microbix Biosystems Inc.
Microbix develops proprietary biological and technology solutions for human health and well-being, with sales now exceeding $1-million per month on average and approximately 80 skilled employees. It makes a wide range of critical biological materials for the global diagnostics industry, notably antigens for immunoassays and its laboratory quality assessment products (QAPs) that support clinical lab proficiency testing, enable assay development and validation, or help ensure quality control of clinical diagnostic tests. Microbix antigens and QAPs are sold to many customers worldwide, at present primarily to multinational diagnostics companies and laboratory accreditation organizations.
We seek Safe Harbor.
© 2020 Canjex Publishing Ltd. All rights reserved.